Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.14 trillion and total revenue of $110.17 billion.
Market Cap
1.14T
Revenue
110.17B
Profits
-39.7B
PE Ratio
n/a
Profit Margin
-36.03%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.74B | -0.15% | 461,294 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.41B | -1.48% | 290,277 | 14.34B |
| 3 | ARGX | argenx SE | 49.22B | 1.33% | 166,838 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.49B | -2.10% | 502,715 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 34.92B | 0.88% | 87,053 | 5.34B |
| 6 | INSM | Insmed Incorporated | 34.58B | 0.01% | 818,246 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 27.95B | 1.15% | 1,156,371 | 2.38B |
| 8 | BNTX | BioNTech SE | 23.26B | -0.10% | 481,329 | 3.37B |
| 9 | ROIV | Roivant Sciences Ltd. | 20.49B | 1.62% | 1,680,184 | 13.31M |
| 10 | MRNA | Moderna, Inc. | 20.26B | -1.94% | 2,372,607 | 1.94B |
| 11 | INCY | Incyte Corporation | 19.31B | 1.18% | 499,942 | 5.14B |
| 12 | RVMD | Revolution Medicines, Inc. | 19.21B | 0.21% | 711,569 | - |
| 13 | GMAB | Genmab A/S | 17.32B | -0.04% | 1,672,110 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 14.96B | 3.81% | 612,256 | 845.52M |
| 15 | SMMT | Summit Therapeutics Inc. | 14.91B | 2.23% | 1,046,989 | - |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.63B | 1.81% | 1,434,471 | 502.08M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.63B | 1.97% | 611,561 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 12.27B | 1.73% | 478,747 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.87B | -0.45% | 97,307 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.76B | 2.47% | 943,636 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.87B | -1.21% | 449,416 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.35B | 4.92% | 797,940 | 5.37M |
| 23 | AXSM | Axsome Therapeutics, Inc. | 9.17B | 3.52% | 333,763 | 638.50M |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.16B | 1.62% | 809,550 | 1.09B |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 8.90B | -0.20% | 175,569 | 7.46M |
| 26 | PCVX | Vaxcyte, Inc. | 8.84B | 2.20% | 734,228 | - |
| 27 | TECH | Bio-Techne Corporation | 8.69B | 0.63% | 1,128,815 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 8.22B | -0.41% | 212,014 | - |
| 29 | HALO | Halozyme Therapeutics, Inc. | 7.98B | 2.90% | 508,123 | 1.40B |
| 30 | CYTK | Cytokinetics, Incorporated | 7.95B | -1.84% | 584,366 | 88.04M |
| 31 | KRYS | Krystal Biotech, Inc. | 7.66B | -1.45% | 117,107 | 389.13M |
| 32 | IBRX | ImmunityBio, Inc. | 7.65B | 6.16% | 16,471,901 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.19B | 1.12% | 214,768 | 39.21M |
| 34 | BLTE | Belite Bio, Inc | 7.13B | 1.46% | 130,492 | - |
| 35 | ACLX | Arcellx, Inc. | 6.74B | - | 258,343 | 22.29M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.62B | 1.58% | 284,537 | 46.02M |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.38B | 3.89% | 403,188 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.14B | 0.51% | 1,263,241 | 15.00M |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.07B | -0.12% | 8,173,111 | - |
| 40 | COGT | Cogent Biosciences, Inc. | 6.01B | 0.97% | 1,689,962 | - |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 5.96B | 0.90% | 243,456 | 521.31M |
| 42 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.95B | 1.88% | 312,559 | 189.76M |
| 43 | CELC | Celcuity Inc. | 5.93B | 4.83% | 625,123 | - |
| 44 | PTCT | PTC Therapeutics, Inc. | 5.91B | 0.25% | 355,184 | 1.73B |
| 45 | CGON | CG Oncology, Inc. | 5.73B | -1.50% | 546,750 | 4.04M |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.59B | -2.64% | 871,402 | - |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.58B | 1.63% | 444,057 | 7.50M |
| 48 | CAI | Caris Life Sciences, Inc. | 5.39B | -2.15% | 991,193 | 812.03M |
| 49 | ERAS | Erasca, Inc. | 5.32B | 1.12% | 2,079,439 | - |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.20B | -0.05% | 4,840,443 | 1.00B |
| 51 | IMVT | Immunovant, Inc. | 5.20B | 3.28% | 1,077,398 | - |
| 52 | TGTX | TG Therapeutics, Inc. | 5.14B | 1.78% | 923,365 | 616.29M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.97B | 0.08% | 624,632 | 3.51M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.81B | 3.90% | 273,709 | 2.04M |
| 55 | FOLD | Amicus Therapeutics, Inc. | 4.54B | 0.03% | 1,171,383 | 634.21M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.47B | 0.41% | 409,364 | 761.41M |
| 57 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.14B | -1.10% | 453,488 | 7.70M |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 4.11B | -0.87% | 187,757 | 268.09M |
| 59 | SYRE | Spyre Therapeutics, Inc. | 4.09B | 0.15% | 351,732 | - |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 4.02B | 2.85% | 228,038 | 22.50M |
| 61 | GPCR | Structure Therapeutics Inc. | 3.95B | 5.10% | 344,830 | - |
| 62 | VKTX | Viking Therapeutics, Inc. | 3.95B | 1.19% | 1,215,608 | - |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 3.85B | 0.09% | 666,936 | 1.07B |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.54B | -0.15% | 302,438 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.41B | 0.66% | 1,081,146 | 1.03B |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.27B | 0.20% | 100,209 | 803.79M |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.14B | 3.65% | 1,102,545 | - |
| 68 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.14B | 1.50% | 749,506 | 588.99M |
| 69 | ORKA | Oruka Therapeutics, Inc. | 3.09B | 0.57% | 541,562 | - |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 3.07B | 0.42% | 112,664 | 451.36M |
| 71 | ARQT | Arcutis Biotherapeutics, Inc. | 3.07B | 0.51% | 511,307 | 376.07M |
| 72 | DNLI | Denali Therapeutics Inc. | 3.06B | -1.68% | 526,655 | - |
| 73 | TVTX | Travere Therapeutics, Inc. | 2.92B | -0.22% | 933,526 | 490.73M |
| 74 | TNGX | Tango Therapeutics, Inc. | 2.92B | 1.97% | 1,265,900 | 62.38M |
| 75 | RCUS | Arcus Biosciences, Inc. | 2.89B | 1.90% | 210,347 | 247.00M |
| 76 | ALMS | Alumis Inc. | 2.88B | -0.22% | 526,691 | 24.05M |
| 77 | VERA | Vera Therapeutics, Inc. | 2.87B | -0.40% | 825,095 | - |
| 78 | IDYA | IDEAYA Biosciences, Inc. | 2.74B | 0.65% | 723,581 | 218.71M |
| 79 | SLNO | Soleno Therapeutics, Inc. | 2.71B | -0.32% | 4,454,891 | 190.41M |
| 80 | ELVN | Enliven Therapeutics, Inc. | 2.71B | 5.47% | 1,432,584 | - |
| 81 | RLAY | Relay Therapeutics, Inc. | 2.64B | 1.86% | 1,817,666 | 15.36M |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.62B | 3.18% | 373,755 | 1.55M |
| 83 | BEAM | Beam Therapeutics Inc. | 2.61B | 3.16% | 1,390,424 | 139.74M |
| 84 | KOD | Kodiak Sciences Inc. | 2.59B | 0.25% | 281,074 | - |
| 85 | IRON | Disc Medicine, Inc. | 2.55B | 0.72% | 72,609 | - |
| 86 | IMNM | Immunome, Inc. | 2.50B | 1.75% | 513,281 | 6.94M |
| 87 | ADMA | ADMA Biologics, Inc. | 2.38B | 1.63% | 2,397,219 | 510.17M |
| 88 | ZLAB | Zai Lab Limited | 2.35B | -2.55% | 726,478 | 460.16M |
| 89 | SRPT | Sarepta Therapeutics, Inc. | 2.34B | 1.74% | 1,123,753 | 2.20B |
| 90 | AAPG | Ascentage Pharma Group International | 2.32B | -5.69% | 1,195 | 82.08M |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.32B | 1.99% | 814,121 | 673.00M |
| 92 | MLYS | Mineralys Therapeutics, Inc. | 2.28B | -0.36% | 381,118 | - |
| 93 | MANE | Veradermics, Incorporated | 2.25B | 3.65% | 86,689 | - |
| 94 | NKTR | Nektar Therapeutics | 2.22B | 3.13% | 305,228 | 55.23M |
| 95 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.14% | 655,412 | 158.18M |
| 96 | SNDX | Syndax Pharmaceuticals, Inc. | 2.17B | 0.08% | 354,578 | 172.35M |
| 97 | DFTX | Definium Therapeutics, Inc. | 2.14B | 2.33% | 886,300 | - |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | 1.04% | 347,359 | 283.06M |
| 99 | ADPT | Adaptive Biotechnologies Corporation | 2.12B | -7.18% | 1,075,012 | 276.98M |
| 100 | STOK | Stoke Therapeutics, Inc. | 2.08B | 0.65% | 301,385 | 184.42M |
| 101 | ZYME | Zymeworks Inc. | 2.02B | 2.62% | 207,512 | 105.97M |
| 102 | ANAB | AnaptysBio, Inc. | 1.98B | 5.23% | 213,487 | 234.60M |
| 103 | TYRA | Tyra Biosciences, Inc. | 1.98B | -1.10% | 579,887 | - |
| 104 | OCUL | Ocular Therapeutix, Inc. | 1.92B | 4.99% | 3,327,071 | 51.95M |
| 105 | AGIO | Agios Pharmaceuticals, Inc. | 1.91B | -3.26% | 355,543 | 54.03M |
| 106 | GLPG | Galapagos NV | 1.89B | -1.33% | 85,913 | 1.31B |
| 107 | PVLA | Palvella Therapeutics, Inc. | 1.88B | 6.67% | 267,433 | - |
| 108 | MESO | Mesoblast Limited | 1.85B | 5.03% | 267,625 | 65.38M |
| 109 | CAPR | Capricor Therapeutics, Inc. | 1.82B | 0.32% | 335,886 | 11.13M |
| 110 | PHVS | Pharvaris N.V. | 1.79B | -0.76% | 43,048 | - |
| 111 | INVA | Innoviva, Inc. | 1.78B | 1.65% | 317,780 | 411.33M |
| 112 | SION | Sionna Therapeutics, Inc. | 1.75B | 5.17% | 232,296 | - |
| 113 | RXRX | Recursion Pharmaceuticals, Inc. | 1.75B | -2.51% | 5,651,955 | 74.68M |
| 114 | TRVI | Trevi Therapeutics, Inc. | 1.73B | 3.06% | 767,672 | - |
| 115 | VCEL | Vericel Corporation | 1.72B | -0.98% | 127,267 | 276.26M |
| 116 | HRMY | Harmony Biosciences Holdings, Inc. | 1.68B | 1.93% | 227,830 | 868.45M |
| 117 | NRIX | Nurix Therapeutics, Inc. | 1.68B | 3.97% | 483,721 | 71.78M |
| 118 | RAPP | Rapport Therapeutics, Inc. | 1.63B | 1.34% | 78,702 | - |
| 119 | NTLA | Intellia Therapeutics, Inc. | 1.63B | -0.79% | 888,773 | 67.67M |
| 120 | OCS | Oculis Holding AG | 1.62B | 0.44% | 65,183 | 1.51M |
| 121 | IMCR | Immunocore Holdings plc | 1.61B | -0.25% | 144,282 | 400.02M |
| 122 | IOVA | Iovance Biotherapeutics, Inc. | 1.59B | 11.53% | 17,912,938 | 263.50M |
| 123 | NUVB | Nuvation Bio Inc. | 1.58B | 1.55% | 1,323,302 | 62.90M |
| 124 | VIR | Vir Biotechnology, Inc. | 1.57B | 3.47% | 1,166,093 | 68.56M |
| 125 | VRDN | Viridian Therapeutics, Inc. | 1.56B | 5.60% | 1,705,237 | 70.85M |
| 126 | DMRA | Damora Therapeutics, Inc. | 1.55B | 0.59% | 107,081 | - |
| 127 | MBX | MBX Biosciences, Inc. | 1.55B | 3.00% | 238,159 | - |
| 128 | SVRA | Savara Inc. | 1.49B | -1.18% | 379,916 | - |
| 129 | PGEN | Precigen, Inc. | 1.48B | 1.82% | 1,334,500 | 9.68M |
| 130 | ARDX | Ardelyx, Inc. | 1.48B | -1.15% | 1,310,744 | 407.32M |
| 131 | GENB | Generate Biomedicines, Inc. | 1.46B | -4.06% | 130,025 | 31.89M |
| 132 | OLMA | Olema Pharmaceuticals, Inc. | 1.46B | 6.76% | 447,684 | - |
| 133 | NBTX | Nanobiotix S.A. | 1.46B | -2.22% | 58,220 | 38.27M |
| 134 | GLUE | Monte Rosa Therapeutics, Inc. | 1.44B | 4.91% | 443,397 | 123.67M |
| 135 | BCAX | Bicara Therapeutics Inc. | 1.42B | 0.56% | 293,586 | - |
| 136 | BHVN | Biohaven Ltd. | 1.42B | 0.59% | 593,682 | - |
| 137 | IMTX | Immatics N.V. | 1.41B | -0.19% | 177,692 | 56.67M |
| 138 | MAZE | Maze Therapeutics, Inc. | 1.38B | -0.93% | 462,848 | 2.50M |
| 139 | NVAX | Novavax, Inc. | 1.38B | 0.71% | 1,401,260 | 1.12B |
| 140 | ATAI | AtaiBeckley Inc. | 1.36B | -0.93% | 1,284,265 | 4.09M |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.36B | 1.67% | 887,215 | - |
| 142 | WVE | Wave Life Sciences Ltd. | 1.34B | 0.07% | 1,356,048 | 42.73M |
| 143 | TSHA | Taysha Gene Therapies, Inc. | 1.33B | 1.76% | 677,222 | 9.77M |
| 144 | CRVS | Corvus Pharmaceuticals, Inc. | 1.30B | 4.03% | 289,538 | - |
| 145 | ZBIO | Zenas BioPharma, Inc. | 1.28B | 3.07% | 264,217 | 10.00M |
| 146 | MPLT | MapLight Therapeutics, Inc. | 1.26B | 18.36% | 293,239 | - |
| 147 | PHAR | Pharming Group N.V. | 1.20B | 1.00% | 596 | 376.13M |
| 148 | AVBP | ArriVent BioPharma, Inc. | 1.19B | 6.81% | 818,173 | - |
| 149 | EYPT | EyePoint, Inc. | 1.17B | -1.20% | 485,271 | 31.37M |
| 150 | DBVT | DBV Technologies S.A. | 1.17B | -0.77% | 78,513 | 5.64M |
| 151 | SEPN | Septerna, Inc. | 1.12B | 1.92% | 101,993 | 45.95M |
| 152 | GERN | Geron Corporation | 1.10B | 0.29% | 13,402,738 | 183.88M |
| 153 | INBX | Inhibrx Biosciences, Inc. | 1.10B | 11.81% | 360,801 | 1.30M |
| 154 | ABCL | AbCellera Biologics Inc. | 1.04B | 0.15% | 1,120,890 | 75.13M |
| 155 | XERS | Xeris Biopharma Holdings, Inc. | 1.03B | 0.51% | 1,119,092 | 291.85M |
| 156 | EVMN | Evommune, Inc. | 1.02B | 4.26% | 132,262 | 13.00M |
| 157 | IVA | Inventiva S.A. | 1.02B | 2.26% | 198,682 | 9.31M |
| 158 | KALV | KalVista Pharmaceuticals, Inc. | 1.02B | 3.06% | 253,605 | 73.62M |
| 159 | QURE | uniQure N.V. | 1.02B | 2.33% | 612,281 | 16.10M |
| 160 | ORIC | ORIC Pharmaceuticals, Inc. | 1.00B | 10.61% | 1,386,781 | - |
| 161 | CMPX | Compass Therapeutics, Inc. | 992.28M | 2.04% | 996,835 | 850.00K |
| 162 | AKTS | Aktis Oncology, Inc. | 983.91M | 4.83% | 158,377 | 6.50M |
| 163 | PHAT | Phathom Pharmaceuticals, Inc. | 983.74M | 4.87% | 901,482 | 175.11M |
| 164 | URGN | UroGen Pharma Ltd. | 979.49M | 5.34% | 842,430 | 109.79M |
| 165 | ANNX | Annexon, Inc. | 976.49M | 0.58% | 597,291 | - |
| 166 | GHRS | GH Research PLC | 941.61M | 1.27% | 25,630 | - |
| 167 | CTMX | CytomX Therapeutics, Inc. | 912.27M | -0.71% | 1,530,543 | 76.20M |
| 168 | CGEM | Cullinan Therapeutics, Inc. | 912.13M | 0.74% | 247,557 | - |
| 169 | SLS | SELLAS Life Sciences Group, Inc. | 904.20M | 3.60% | 3,915,487 | - |
| 170 | XNCR | Xencor, Inc. | 902.07M | 0.41% | 399,059 | 125.58M |
| 171 | JBIO | Jade Biosciences, Inc. | 889.17M | 7.58% | 823,845 | - |
| 172 | JANX | Janux Therapeutics, Inc. | 885.10M | 0.14% | 245,037 | 10.00M |
| 173 | FTRE | Fortrea Holdings Inc. | 873.29M | -3.01% | 410,261 | 2.72B |
| 174 | TBPH | Theravance Biopharma, Inc. | 849.12M | -0.66% | 119,950 | 107.46M |
| 175 | OMER | Omeros Corporation | 844.52M | 1.91% | 722,643 | - |
| 176 | VOR | Vor Biopharma Inc. | 842.59M | -1.24% | 603,652 | - |
| 177 | SANA | Sana Biotechnology, Inc. | 837.96M | -2.18% | 719,899 | - |
| 178 | ABUS | Arbutus Biopharma Corporation | 834.69M | -2.51% | 1,304,588 | 14.08M |
| 179 | SPRY | ARS Pharmaceuticals, Inc. | 832.61M | 2.38% | 1,412,992 | 84.28M |
| 180 | DRUG | Bright Minds Biosciences Inc. | 805.65M | 1.47% | 191,433 | - |
| 181 | MNKD | MannKind Corporation | 804.14M | - | 1,383,378 | 348.97M |
| 182 | SLDB | Solid Biosciences Inc. | 800.91M | 1.50% | 351,013 | - |
| 183 | MRVI | Maravai LifeSciences Holdings, Inc. | 796.91M | -0.32% | 1,087,983 | 185.74M |
| 184 | RLMD | Relmada Therapeutics, Inc. | 791.91M | 7.70% | 1,262,120 | - |
| 185 | KURA | Kura Oncology, Inc. | 779.95M | 0.46% | 360,954 | 67.48M |
| 186 | DSGN | Design Therapeutics, Inc. | 772.14M | -1.18% | 93,658 | - |
| 187 | TENX | Tenax Therapeutics, Inc. | 767.58M | 1.40% | 655,295 | - |
| 188 | LXRX | Lexicon Pharmaceuticals, Inc. | 764.74M | 8.08% | 2,927,992 | 49.80M |
| 189 | MGTX | MeiraGTx Holdings plc | 763.15M | -0.21% | 194,526 | 81.39M |
| 190 | ARVN | Arvinas, Inc. | 718.92M | 0.27% | 252,650 | 262.60M |
| 191 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 717.89M | 3.82% | 217,216 | - |
| 192 | SGP | SpyGlass Pharma, Inc. | 713.66M | -3.92% | 46,702 | - |
| 193 | ANRO | Alto Neuroscience, Inc. | 703.12M | 1.38% | 105,803 | - |
| 194 | ALLO | Allogene Therapeutics, Inc. | 682.58M | 3.70% | 3,264,509 | 22.00K |
| 195 | LBRX | LB Pharmaceuticals Inc | 661.32M | 0.62% | 203,349 | - |
| 196 | GYRE | Gyre Therapeutics, Inc. | 660.66M | 2.05% | 21,019 | 116.59M |
| 197 | DRTS | Alpha Tau Medical Ltd. | 650.39M | 2.64% | 228,494 | - |
| 198 | FBRX | Forte Biosciences, Inc. | 641.12M | 30.03% | 2,044,376 | - |
| 199 | CBIO | Crescent Biopharma, Inc. | 640.03M | 5.19% | 63,097 | 10.84M |
| 200 | OCGN | Ocugen, Inc. | 636.94M | 1.34% | 3,590,765 | 4.41M |
| 201 | PRME | Prime Medicine, Inc. | 616.24M | -1.69% | 736,276 | 4.63M |
| 202 | MDXG | MiMedx Group, Inc. | 595.01M | 0.88% | 705,267 | 418.63M |
| 203 | CRMD | CorMedix Inc. | 579.04M | 1.31% | 375,560 | 311.71M |
| 204 | PRTA | Prothena Corporation plc | 571.71M | -0.28% | 182,945 | 9.68M |
| 205 | TECX | Tectonic Therapeutic, Inc. | 571.56M | 1.26% | 80,661 | - |
| 206 | PROK | ProKidney Corp. | 567.60M | 1.62% | 232,512 | 893.00K |
| 207 | KYTX | Kyverna Therapeutics, Inc. | 566.29M | 1.60% | 425,670 | - |
| 208 | ZVRA | Zevra Therapeutics, Inc. | 563.63M | 0.10% | 347,086 | 106.47M |
| 209 | RIGL | Rigel Pharmaceuticals, Inc. | 561.40M | 2.22% | 214,429 | 294.28M |
| 210 | UPB | Upstream Bio, Inc. | 558.89M | 4.37% | 486,539 | 2.85M |
| 211 | LYEL | Lyell Immunopharma, Inc. | 553.47M | 3.56% | 78,019 | 36.00K |
| 212 | ACRS | Aclaris Therapeutics, Inc. | 552.51M | 0.63% | 646,836 | 7.83M |
| 213 | VALN | Valneva SE | 546.53M | -1.76% | 14,174 | 205.07M |
| 214 | ZURA | Zura Bio Limited | 536.08M | -0.88% | 385,882 | - |
| 215 | LRMR | Larimar Therapeutics, Inc. | 529.80M | 0.20% | 657,474 | - |
| 216 | STTK | Shattuck Labs, Inc. | 529.58M | 5.41% | 753,354 | 1.00M |
| 217 | FULC | Fulcrum Therapeutics, Inc. | 526.14M | - | 358,464 | 80.00M |
| 218 | IMMX | Immix Biopharma, Inc. | 510.24M | 10.00% | 749,513 | - |
| 219 | AGMB | AgomAb Therapeutics NV | 506.86M | 5.58% | 174,059 | - |
| 220 | FDMT | 4D Molecular Therapeutics, Inc. | 504.90M | -2.08% | 198,070 | 85.21M |
| 221 | TRDA | Entrada Therapeutics, Inc. | 504.00M | -2.23% | 67,682 | 25.42M |
| 222 | REPL | Replimune Group, Inc. | 502.04M | 3.31% | 5,925,356 | - |
| 223 | VSTM | Verastem, Inc. | 492.32M | 2.84% | 951,831 | 30.91M |
| 224 | EIKN | Eikon Therapeutics, Inc. | 488.33M | -5.05% | 148,435 | - |
| 225 | ENGN | enGene Holdings Inc. | 485.00M | -0.96% | 106,940 | - |
| 226 | CTNM | Contineum Therapeutics, Inc. | 482.01M | 0.94% | 71,793 | - |
| 227 | LXEO | Lexeo Therapeutics, Inc. | 480.08M | 0.62% | 298,641 | - |
| 228 | IVVD | Invivyd, Inc. | 479.35M | 25.56% | 9,883,688 | 53.43M |
| 229 | ADCT | ADC Therapeutics SA | 478.32M | 0.94% | 335,082 | 81.36M |
| 230 | ASMB | Assembly Biosciences, Inc. | 473.34M | 1.67% | 73,526 | 72.30M |
| 231 | VTVT | vTv Therapeutics Inc. | 470.44M | -1.43% | 48,592 | 17.00K |
| 232 | AVIR | Atea Pharmaceuticals, Inc. | 462.89M | -2.02% | 102,945 | - |
| 233 | RGNX | REGENXBIO Inc. | 460.17M | 2.83% | 223,607 | 170.44M |
| 234 | ABSI | Absci Corporation | 452.18M | -1.17% | 1,752,849 | 2.80M |
| 235 | ANL | Adlai Nortye Ltd. | 440.22M | -0.83% | 431,863 | -1.35M |
| 236 | AURA | Aura Biosciences, Inc. | 438.79M | 1.03% | 166,425 | - |
| 237 | STRO | Sutro Biopharma, Inc. | 438.04M | -2.26% | 143,841 | 102.48M |
| 238 | ALT | Altimmune, Inc. | 437.15M | -0.30% | 895,559 | 41.00K |
| 239 | VNDA | Vanda Pharmaceuticals Inc. | 428.53M | -0.55% | 435,078 | 216.11M |
| 240 | XOMA | XOMA Royalty Corporation | 428.37M | 3.72% | 169,424 | 52.15M |
| 241 | EPRX | Eupraxia Pharmaceuticals Inc. | 420.16M | 2.33% | 97,579 | - |
| 242 | ARMP | Armata Pharmaceuticals, Inc. | 413.95M | -6.77% | 25,937 | 4.90M |
| 243 | NAUT | Nautilus Biotechnology, Inc. | 408.80M | 3.19% | 113,727 | - |
| 244 | IPSC | Century Therapeutics, Inc. | 407.97M | -0.87% | 1,201,614 | 109.16M |
| 245 | ENTA | Enanta Pharmaceuticals, Inc. | 405.40M | 1.45% | 33,881 | 66.98M |
| 246 | YDES | YD Bio Limited | 400.82M | -1.04% | 13,180 | 510.36K |
| 247 | AUTL | Autolus Therapeutics plc | 396.55M | - | 1,784,569 | 75.39M |
| 248 | RCKT | Rocket Pharmaceuticals, Inc. | 392.84M | - | 1,435,851 | - |
| 249 | IRD | Opus Genetics, Inc. | 392.74M | 7.18% | 760,511 | 14.20M |
| 250 | PBYI | Puma Biotechnology, Inc. | 391.23M | 2.39% | 198,074 | 228.37M |
| 251 | PRTC | PureTech Health plc | 391.19M | 4.65% | 1,648 | 6.39M |
| 252 | MNPR | Monopar Therapeutics Inc. | 387.27M | -0.28% | 313,335 | - |
| 253 | NMRA | Neumora Therapeutics, Inc. | 380.47M | -4.13% | 608,444 | - |
| 254 | OVID | Ovid Therapeutics Inc. | 380.46M | 10.96% | 5,117,438 | 7.25M |
| 255 | CLYM | Climb Bio, Inc. | 374.98M | 10.56% | 351,651 | - |
| 256 | LCTX | Lineage Cell Therapeutics, Inc. | 374.88M | -2.27% | 536,154 | 14.56M |
| 257 | BNTC | Benitec Biopharma Inc. | 374.41M | -1.18% | 51,378 | - |
| 258 | DNA | Ginkgo Bioworks Holdings, Inc. | 372.53M | -6.98% | 659,983 | 170.16M |
| 259 | RZLT | Rezolute, Inc. | 370.82M | 0.28% | 576,040 | - |
| 260 | XFOR | X4 Pharmaceuticals, Inc. | 370.04M | 0.49% | 238,959 | 35.11M |
| 261 | IMRX | Immuneering Corporation | 362.06M | 1.82% | 432,848 | - |
| 262 | NAGE | Niagen Bioscience, Inc. | 359.51M | -2.61% | 300,661 | 129.42M |
| 263 | GLSI | Greenwich LifeSciences, Inc. | 354.81M | 5.83% | 154,853 | - |
| 264 | CADL | Candel Therapeutics, Inc. | 353.78M | -2.42% | 537,823 | - |
| 265 | PRLD | Prelude Therapeutics Incorporated | 346.64M | -0.47% | 145,373 | 12.14M |
| 266 | BCYC | Bicycle Therapeutics plc | 346.44M | -0.20% | 168,390 | 72.59M |
| 267 | CABA | Cabaletta Bio, Inc. | 345.10M | 0.32% | 1,345,495 | - |
| 268 | NGEN | NervGen Pharma Corp. | 341.53M | 0.96% | 118,121 | - |
| 269 | ACIU | AC Immune SA | 335.30M | 5.30% | 398,252 | 4.51M |
| 270 | DMAC | DiaMedica Therapeutics Inc. | 335.15M | 0.48% | 179,044 | - |
| 271 | NGNE | Neurogene Inc. | 330.95M | -1.67% | 59,370 | 925.00K |
| 272 | PALI | Palisade Bio, Inc. | 328.15M | 4.81% | 2,615,135 | - |
| 273 | AVTX | Avalo Therapeutics, Inc. | 323.94M | -1.35% | 717,822 | 59.00K |
| 274 | SRZN | Surrozen, Inc. | 307.61M | 3.28% | 35,087 | 3.48M |
| 275 | ABEO | Abeona Therapeutics Inc. | 296.65M | 6.78% | 758,848 | 5.82M |
| 276 | ZNTL | Zentalis Pharmaceuticals, Inc. | 296.14M | 51.27% | 9,559,476 | 26.87M |
| 277 | IKT | Inhibikase Therapeutics, Inc. | 289.72M | -2.30% | 634,454 | 1.00 |
| 278 | LENZ | LENZ Therapeutics, Inc. | 289.40M | -2.33% | 255,665 | 19.09M |
| 279 | TARA | Protara Therapeutics, Inc. | 283.13M | 0.29% | 225,047 | - |
| 280 | AVXL | Anavex Life Sciences Corp. | 283.11M | 0.49% | 485,701 | - |
| 281 | FHTX | Foghorn Therapeutics Inc. | 281.76M | -1.84% | 200,959 | 30.91M |
| 282 | EDIT | Editas Medicine, Inc. | 279.91M | 3.62% | 910,145 | 40.52M |
| 283 | NBP | NovaBridge Biosciences | 278.43M | -1.43% | 390,133 | - |
| 284 | PLYX | Polaryx Therapeutics, Inc. | 276.01M | 1.57% | 111,693 | - |
| 285 | CCCC | C4 Therapeutics, Inc. | 271.27M | -4.14% | 17,841,708 | 35.95M |
| 286 | SLN | Silence Therapeutics plc | 268.29M | -2.91% | 135,522 | 559.00K |
| 287 | SABS | SAB Biotherapeutics, Inc. | 268.10M | 2.28% | 173,209 | 114.70K |
| 288 | HELP | Cybin Inc. | 264.19M | 0.57% | 222,875 | - |
| 289 | CLLS | Cellectis S.A. | 262.12M | -2.54% | 5,771 | 79.59M |
| 290 | ALEC | Alector, Inc. | 261.01M | -2.27% | 134,880 | 21.05M |
| 291 | ADAG | Adagene Inc. | 258.01M | -2.38% | 584,267 | 7.67M |
| 292 | OBIO | Orchestra BioMed Holdings, Inc. | 248.71M | -0.47% | 82,877 | 33.48M |
| 293 | CHRS | Coherus Oncology, Inc. | 248.07M | -2.65% | 768,159 | 42.17M |
| 294 | KROS | Keros Therapeutics, Inc. | 247.85M | 0.16% | 157,046 | 244.06M |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 241.91M | -0.67% | 57,173 | 19.39M |
| 296 | MIST | Milestone Pharmaceuticals Inc. | 239.17M | 9.55% | 9,939,791 | 1.55M |
| 297 | NERV | Minerva Neurosciences, Inc. | 238.87M | 1.85% | 220,596 | - |
| 298 | CNTX | Context Therapeutics Inc. | 237.97M | -1.89% | 411,076 | - |
| 299 | ELDN | Eledon Pharmaceuticals, Inc. | 237.39M | -0.16% | 622,693 | - |
| 300 | VYGR | Voyager Therapeutics, Inc. | 235.72M | 0.89% | 353,636 | 40.37M |
| 301 | ARCT | Arcturus Therapeutics Holdings Inc. | 235.63M | -2.47% | 209,028 | 82.03M |
| 302 | CGEN | Compugen Ltd. | 233.08M | 7.64% | 309,129 | 72.76M |
| 303 | CAMP | Camp4 Therapeutics Corporation | 231.82M | -2.51% | 21,238 | 3.50M |
| 304 | MDWD | MediWound Ltd. | 226.91M | 2.23% | 60,153 | 16.96M |
| 305 | FENC | Fennec Pharmaceuticals Inc. | 222.02M | -0.77% | 41,242 | 44.64M |
| 306 | ALXO | ALX Oncology Holdings Inc. | 221.10M | -11.35% | 1,473,186 | - |
| 307 | ENLV | Enlivex Ltd. | 220.38M | -0.50% | 178,846 | - |
| 308 | OABI | OmniAb, Inc. | 216.45M | -1.64% | 119,735 | 18.67M |
| 309 | MGNX | MacroGenics, Inc. | 215.45M | -1.74% | 556,843 | 149.50M |
| 310 | NVCT | Nuvectis Pharma, Inc. | 214.58M | -0.49% | 13,702 | - |
| 311 | MENS | Jyong Biotech Ltd. | 214.47M | 4.06% | 60,449 | - |
| 312 | CDXS | Codexis, Inc. | 213.09M | 6.11% | 2,274,943 | 70.39M |
| 313 | PRQR | ProQR Therapeutics N.V. | 205.45M | 6.56% | 1,684,551 | 19.19M |
| 314 | KRRO | Korro Bio, Inc. | 191.24M | -1.49% | 44,215 | 6.39M |
| 315 | ELTX | Elicio Therapeutics, Inc. | 190.86M | 2.42% | 66,160 | - |
| 316 | CRBU | Caribou Biosciences, Inc. | 190.38M | 1.03% | 644,246 | 11.16M |
| 317 | TNXP | Tonix Pharmaceuticals Holding Corp. | 189.22M | 2.15% | 232,111 | 13.11M |
| 318 | CNTN | Canton Strategic Holdings, Inc. | 186.97M | 0.61% | 293,044 | - |
| 319 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 184.10M | 5.49% | 120,710 | - |
| 320 | ABOS | Acumen Pharmaceuticals, Inc. | 183.42M | -1.55% | 298,361 | - |
| 321 | PLX | Protalix BioTherapeutics, Inc. | 182.90M | 0.89% | 589,599 | 52.74M |
| 322 | SGMT | Sagimet Biosciences Inc. | 182.80M | 0.36% | 160,522 | - |
| 323 | KPTI | Karyopharm Therapeutics Inc. | 181.47M | 11.03% | 807,309 | 146.07M |
| 324 | ACHV | Achieve Life Sciences, Inc. | 173.56M | - | 210,993 | - |
| 325 | WHWK | Whitehawk Therapeutics, Inc. | 172.98M | 7.48% | 186,459 | 7.15M |
| 326 | AGEN | Agenus Inc. | 171.45M | 6.31% | 729,321 | 114.20M |
| 327 | UNCY | Unicycive Therapeutics, Inc. | 168.59M | 3.57% | 300,948 | - |
| 328 | NKTX | Nkarta, Inc. | 167.53M | 1.73% | 288,531 | - |
| 329 | ARTV | Artiva Biotherapeutics, Inc. | 165.60M | 8.24% | 176,264 | 251.00K |
| 330 | IMUX | Immunic, Inc. | 164.39M | 5.88% | 986,726 | - |
| 331 | DTIL | Precision BioSciences, Inc. | 164.37M | 6.34% | 121,108 | 34.26M |
| 332 | RNAC | Cartesian Therapeutics, Inc. | 164.36M | 0.81% | 89,729 | 2.80M |
| 333 | TNYA | Tenaya Therapeutics, Inc. | 160.64M | 2.08% | 3,056,022 | - |
| 334 | TLSA | Tiziana Life Sciences Ltd | 160.17M | -1.18% | 116,027 | - |
| 335 | CNTB | Connect Biopharma Holdings Limited | 159.96M | 7.60% | 183,101 | 64.00K |
| 336 | SPRO | Spero Therapeutics, Inc. | 159.20M | 1.10% | 325,845 | 66.80M |
| 337 | MOLN | Molecular Partners AG | 158.23M | 2.17% | 3,153 | 856.30K |
| 338 | GALT | Galectin Therapeutics Inc. | 155.68M | 6.53% | 242,779 | - |
| 339 | HRTX | Heron Therapeutics, Inc. | 153.64M | -2.06% | 955,524 | 154.90M |
| 340 | BDTX | Black Diamond Therapeutics, Inc. | 146.66M | 2.40% | 568,779 | 70.00M |
| 341 | FATE | Fate Therapeutics, Inc. | 145.91M | 6.36% | 975,825 | 6.65M |
| 342 | ORMP | Oramed Pharmaceuticals Inc. | 140.35M | -0.29% | 51,636 | 2.00M |
| 343 | HUMA | Humacyte, Inc. | 139.29M | -3.70% | 2,917,181 | 2.04M |
| 344 | ACOG | Alpha Cognition Inc. | 137.18M | -5.05% | 41,398 | 10.22M |
| 345 | KLRS | Kalaris Therapeutics, Inc. | 135.51M | -6.78% | 49,521 | - |
| 346 | BMEA | Biomea Fusion, Inc. | 133.03M | 4.55% | 1,726,763 | - |
| 347 | IPHA | Innate Pharma S.A. | 128.37M | -0.98% | 48,877 | 10.57M |
| 348 | HURA | TuHURA Biosciences, Inc. | 124.30M | 8.01% | 1,140,974 | - |
| 349 | EQ | Equillium, Inc. | 119.50M | 5.00% | 177,159 | 4.39M |
| 350 | NTHI | NeOnc Technologies Holdings, Inc. | 119.03M | -6.89% | 33,917 | 39.99K |
| 351 | ANTX | AN2 Therapeutics, Inc. | 116.81M | -2.69% | 57,588 | - |
| 352 | ONCY | Oncolytics Biotech Inc. | 115.95M | 10.22% | 1,507,455 | - |
| 353 | PEPG | PepGen Inc. | 112.66M | -1.81% | 745,566 | - |
| 354 | SGMO | Sangamo Therapeutics, Inc. | 112.14M | 6.28% | 4,773,919 | 39.55M |
| 355 | PMN | ProMIS Neurosciences, Inc. | 112.10M | 16.82% | 40,031 | - |
| 356 | CRDF | Cardiff Oncology, Inc. | 111.43M | 4.49% | 705,979 | 593.00K |
| 357 | GNLX | Genelux Corporation | 104.72M | -10.61% | 780,812 | 8.00K |
| 358 | KZIA | Kazia Therapeutics Limited | 104.44M | 0.44% | 58,035 | 1.27M |
| 359 | COYA | Coya Therapeutics, Inc. | 104.38M | 8.27% | 261,052 | 7.95M |
| 360 | TTRX | Turn Therapeutics Inc. | 104.26M | - | 14,106 | - |
| 361 | CBUS | Cibus, Inc. | 103.60M | -7.17% | 613,828 | 3.64M |
| 362 | VRCA | Verrica Pharmaceuticals Inc. | 98.78M | -1.20% | 14,965 | 35.58M |
| 363 | EXOZ | eXoZymes, Inc. | 98.53M | 11.20% | 6,013 | -700.00 |
| 364 | PYXS | Pyxis Oncology, Inc. | 98.02M | 6.12% | 551,339 | 13.86M |
| 365 | SEER | Seer, Inc. | 94.79M | -0.59% | 80,224 | 16.58M |
| 366 | ALDX | Aldeyra Therapeutics, Inc. | 94.19M | -0.32% | 1,859,379 | - |
| 367 | LONA | LeonaBio, Inc. | 93.28M | 3.65% | 19,592 | - |
| 368 | SPRB | Spruce Biosciences, Inc. | 92.34M | 5.73% | 73,493 | 697.00K |
| 369 | ANIX | Anixa Biosciences, Inc. | 91.53M | - | 48,146 | - |
| 370 | GOSS | Gossamer Bio, Inc. | 88.48M | 8.52% | 5,298,801 | 48.47M |
| 371 | VANI | Vivani Medical, Inc. | 88.46M | -1.42% | 34,200 | - |
| 372 | INO | Inovio Pharmaceuticals, Inc. | 87.30M | -1.83% | 2,211,080 | 65.34K |
| 373 | AARD | Aardvark Therapeutics, Inc. | 85.30M | -0.51% | 101,726 | - |
| 374 | MCRB | Seres Therapeutics, Inc. | 85.22M | 1.48% | 7,120 | 789.00K |
| 375 | PLRX | Pliant Therapeutics, Inc. | 83.89M | -0.37% | 181,154 | - |
| 376 | OKYO | OKYO Pharma Limited | 83.44M | - | 60,337 | - |
| 377 | FLNA | Filana Therapeutics, Inc. | 81.88M | -0.29% | 122,512 | - |
| 378 | PYPD | PolyPid Ltd. | 81.40M | 0.84% | 10,457 | - |
| 379 | CSBR | Champions Oncology, Inc. | 81.24M | -2.99% | 8,135 | 57.95M |
| 380 | NRXS | NeurAxis, Inc. | 80.55M | 1.41% | 73,158 | 3.57M |
| 381 | ESLA | Estrella Immunopharma, Inc. | 79.36M | -3.12% | 106,443 | - |
| 382 | GANX | Gain Therapeutics, Inc. | 77.94M | 2.50% | 198,488 | - |
| 383 | RANI | Rani Therapeutics Holdings, Inc. | 77.78M | -6.15% | 1,040,853 | 1.63M |
| 384 | CGTX | Cognition Therapeutics, Inc. | 76.25M | -3.04% | 635,868 | - |
| 385 | FBIO | Fortress Biotech, Inc. | 76.00M | 2.16% | 132,122 | 63.26M |
| 386 | IBIO | iBio, Inc. | 76.00M | -1.79% | 342,389 | 300.00K |
| 387 | COEP | Coeptis Therapeutics Holdings, Inc. | 75.67M | 12.07% | 58,667 | 1.36M |
| 388 | PTHS | Pelthos Therapeutics Inc. | 75.50M | -1.75% | 3,074 | 16.80M |
| 389 | ATYR | aTyr Pharma, Inc. | 75.34M | -3.93% | 835,697 | 190.00K |
| 390 | NRXP | NRx Pharmaceuticals, Inc. | 75.15M | 1.11% | 288,781 | 1.23M |
| 391 | BYSI | BeyondSpring Inc. | 74.42M | 2.84% | 6,325 | 1.88M |
| 392 | IFRX | InflaRx N.V. | 73.74M | 7.37% | 602,398 | 34.44K |
| 393 | ACET | Adicet Bio, Inc. | 73.31M | 4.12% | 147,183 | - |
| 394 | IBO | Impact BioMedical Inc. | 72.90M | -4.77% | 84,291 | 32.00K |
| 395 | GUTS | Fractyl Health, Inc. | 72.54M | -1.69% | 673,381 | 3.00K |
| 396 | MAIA | MAIA Biotechnology, Inc. | 72.50M | -3.63% | 680,828 | - |
| 397 | MNOV | MediciNova, Inc. | 71.37M | 0.69% | 8,489 | 409.66K |
| 398 | XBIT | XBiotech Inc. | 71.34M | - | 14,636 | - |
| 399 | QTTB | Q32 Bio Inc. | 71.10M | -11.15% | 271,053 | 53.74M |
| 400 | PMVP | PMV Pharmaceuticals, Inc. | 70.93M | 6.40% | 222,944 | - |
| 401 | CING | Cingulate Inc. | 69.89M | 2.74% | 219,949 | - |
| 402 | ATHE | Alterity Therapeutics Limited | 69.08M | -1.39% | 11,667 | 4.43M |
| 403 | DWTX | Dogwood Therapeutics, Inc. | 66.80M | 3.09% | 33,693 | - |
| 404 | ICCC | ImmuCell Corporation | 65.05M | 12.70% | 79,526 | 27.64M |
| 405 | ACRV | Acrivon Therapeutics, Inc. | 60.83M | 2.61% | 535,867 | - |
| 406 | OKUR | OnKure Therapeutics, Inc. | 60.16M | 0.46% | 149,546 | - |
| 407 | PDSB | PDS Biotechnology Corporation | 59.72M | 8.08% | 1,293,961 | - |
| 408 | TCRX | TScan Therapeutics, Inc. | 59.18M | -1.89% | 503,229 | 10.33M |
| 409 | TIL | Instil Bio, Inc. | 57.41M | -0.88% | 6,722 | - |
| 410 | HYFT | MindWalk Holdings Corp. | 56.12M | 0.89% | 163,406 | 20.70M |
| 411 | INKT | MiNK Therapeutics, Inc. | 55.67M | 0.54% | 13,184 | - |
| 412 | OSTX | OS Therapies Incorporated | 55.07M | 4.80% | 993,430 | - |
| 413 | GRCE | Grace Therapeutics, Inc. | 54.78M | -0.84% | 492,972 | - |
| 414 | EDSA | Edesa Biotech, Inc. | 54.38M | 2.68% | 140,234 | - |
| 415 | KZR | Kezar Life Sciences, Inc. | 54.11M | -0.54% | 28,583 | - |
| 416 | IMA | ImageneBio, Inc. | 53.69M | 5.03% | 15,450 | 800.00K |
| 417 | ENTX | Entera Bio Ltd. | 53.15M | -2.56% | 41,296 | 42.00K |
| 418 | RADX | Radiopharm Theranostics Limited | 52.53M | 0.45% | 7,254 | 10.86M |
| 419 | MGX | Metagenomi Therapeutics, Inc. | 51.73M | -1.08% | 94,114 | 25.21M |
| 420 | MREO | Mereo BioPharma Group plc | 50.55M | -0.78% | 848,428 | 500.00K |
| 421 | XLO | Xilio Therapeutics, Inc. | 49.50M | -1.50% | 6,792 | 43.77M |
| 422 | NTRB | Nutriband Inc. | 48.62M | 2.04% | 6,697 | 2.28M |
| 423 | ALGS | Aligos Therapeutics, Inc. | 48.45M | -2.00% | 8,923 | 2.19M |
| 424 | ANVS | Annovis Bio, Inc. | 46.64M | -28.48% | 5,753,577 | - |
| 425 | LSTA | Lisata Therapeutics, Inc. | 45.16M | - | 7,959 | 170.00K |
| 426 | TELO | Telomir Pharmaceuticals, Inc. | 44.70M | -2.26% | 16,238 | - |
| 427 | RNXT | RenovoRx, Inc. | 43.81M | 3.57% | 235,162 | 1.12M |
| 428 | ACTU | Actuate Therapeutics, Inc. | 43.75M | -3.91% | 76,215 | - |
| 429 | RLYB | Rallybio Corporation | 43.32M | -0.36% | 26,735 | 858.00K |
| 430 | HOWL | Werewolf Therapeutics, Inc. | 43.28M | -9.53% | 178,454 | 1.14M |
| 431 | ATOS | Atossa Therapeutics, Inc. | 43.07M | 3.77% | 31,157 | - |
| 432 | RNTX | Rein Therapeutics Inc. | 42.90M | -2.55% | 33,410 | - |
| 433 | IMMP | Immutep Limited | 42.65M | -7.88% | 776,234 | 5.28M |
| 434 | LITS | Lite Strategy, Inc. | 42.18M | 1.75% | 100,023 | - |
| 435 | SNSE | Sensei Biotherapeutics, Inc. | 41.48M | -2.40% | 35,049 | - |
| 436 | NXTC | NextCure, Inc. | 40.05M | 0.81% | 123,020 | - |
| 437 | VERU | Veru Inc. | 39.40M | -3.73% | 41,702 | 16.89M |
| 438 | CELU | Celularity Inc. | 39.22M | -0.73% | 10,581 | 40.58M |
| 439 | ATRA | Atara Biotherapeutics, Inc. | 38.44M | -6.19% | 97,795 | 120.77M |
| 440 | HYPD | Hyperion DeFi, Inc. | 38.16M | 4.36% | 145,640 | 813.46K |
| 441 | CRVO | CervoMed Inc. | 37.50M | 0.25% | 20,466 | 4.01M |
| 442 | PASG | Passage Bio, Inc. | 34.97M | 17.33% | 78,123 | - |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | 34.53M | -5.33% | 56,604 | 90.00K |
| 444 | EVAX | Evaxion A/S | 34.19M | 0.99% | 20,389 | 7.53M |
| 445 | INMB | INmune Bio Inc. | 34.16M | -0.39% | 170,710 | 50.00K |
| 446 | PLUR | Pluri Inc. | 34.07M | 0.89% | 770 | 1.34M |
| 447 | ABVC | ABVC BioPharma, Inc. | 33.85M | -3.52% | 190,242 | 797.92K |
| 448 | CVM | CEL-SCI Corporation | 33.75M | -5.01% | 40,065 | - |
| 449 | LIXT | Lixte Biotechnology Holdings, Inc. | 33.46M | 1.05% | 9,027 | - |
| 450 | LGVN | Longeveron Inc. | 32.50M | -1.77% | 481,245 | 1.20M |
| 451 | DYAI | Dyadic International, Inc. | 32.06M | -1.43% | 6,183 | 3.09M |
| 452 | BCTX | BriaCell Therapeutics Corp. | 31.99M | 3.39% | 181,004 | - |
| 453 | APLM | Apollomics, Inc. | 31.61M | -4.42% | 2,075 | 6.93M |
| 454 | PTN | Palatin Technologies, Inc. | 30.80M | -2.40% | 12,793 | 8.96M |
| 455 | KYNB | Kyntra Bio, Inc. | 29.30M | -0.82% | 11,003 | 6.44M |
| 456 | IGC | IGC Pharma, Inc. | 28.96M | 7.93% | 1,137,511 | 1.11M |
| 457 | CUE | Cue Biopharma, Inc. | 28.64M | 7.12% | 8,422,741 | 27.47M |
| 458 | MRKR | Marker Therapeutics, Inc. | 28.51M | 17.12% | 595,755 | 3.55M |
| 459 | TVRD | Tvardi Therapeutics, Inc. | 27.11M | -5.25% | 22,381 | - |
| 460 | DARE | Daré Bioscience, Inc. | 27.07M | 0.51% | 48,202 | 1.03M |
| 461 | SNTI | Senti Biosciences, Inc. | 26.50M | -0.13% | 75,387 | 22.00K |
| 462 | XCUR | Exicure, Inc. | 26.37M | 2.66% | 7,760 | 500.00K |
| 463 | BOLD | Boundless Bio, Inc. | 26.22M | 1.74% | 37,907 | - |
| 464 | PSTV | Plus Therapeutics, Inc. | 25.46M | 17.03% | 746,793 | 5.21M |
| 465 | NRSN | NeuroSense Therapeutics Ltd. | 25.12M | -1.46% | 94,096 | - |
| 466 | NEUP | Neuphoria Therapeutics Inc. | 24.85M | -1.91% | 40,994 | 14.99M |
| 467 | LEXX | Lexaria Bioscience Corp. | 24.14M | 1.55% | 49,149 | 522.00K |
| 468 | SKYE | Skye Bioscience, Inc. | 24.12M | 2.18% | 62,111 | - |
| 469 | SER | Serina Therapeutics, Inc. | 24.01M | -3.47% | 62,514 | 130.00K |
| 470 | TVGN | Tevogen Bio Holdings Inc. | 23.94M | -1.03% | 19,984 | - |
| 471 | OTLK | Outlook Therapeutics, Inc. | 23.85M | -8.84% | 4,099,450 | 205.70K |
| 472 | AEON | AEON Biopharma, Inc. | 22.78M | 0.01% | 25,545 | - |
| 473 | JSPR | Jasper Therapeutics, Inc. | 22.73M | 14.84% | 955,067 | - |
| 474 | TPST | Tempest Therapeutics, Inc. | 22.66M | 1.28% | 76,224 | - |
| 475 | BRNS | Barinthus Biotherapeutics plc | 22.47M | -6.65% | 9,017 | 14.97M |
| 476 | NNVC | NanoViricides, Inc. | 21.81M | -8.18% | 124,911 | - |
| 477 | VTGN | Vistagen Therapeutics, Inc. | 21.59M | -0.95% | 138,407 | 789.00K |
| 478 | LTRN | Lantern Pharma Inc. | 21.41M | -1.55% | 129,534 | - |
| 479 | QNTM | Quantum BioPharma Ltd. | 20.84M | -11.41% | 187,561 | - |
| 480 | VYNE | VYNE Therapeutics Inc. | 20.64M | 1.56% | 23,492 | 570.00K |
| 481 | CRIS | Curis, Inc. | 20.38M | -6.61% | 246,912 | 9.44M |
| 482 | COCP | Cocrystal Pharma, Inc. | 20.27M | 2.08% | 470,143 | - |
| 483 | CTXR | Citius Pharmaceuticals, Inc. | 18.73M | 0.85% | 214,256 | 3.94M |
| 484 | KTTA | Pasithea Therapeutics Corp. | 18.70M | -2.10% | 2,436,093 | - |
| 485 | PLRZ | Polyrizon Ltd. | 18.65M | 1.77% | 8,721 | - |
| 486 | ALLR | Allarity Therapeutics, Inc. | 18.35M | - | 39,503 | 320.00K |
| 487 | ICU | SeaStar Medical Holding Corporation | 16.80M | 0.61% | 60,072 | 1.23M |
| 488 | OSRH | OSR Holdings, Inc. | 16.37M | 0.47% | 1,496,587 | 2.91M |
| 489 | GNTA | Genenta Science S.p.A. | 15.81M | -5.30% | 28,134 | - |
| 490 | HIND | Vyome Holdings, Inc. | 15.79M | 5.63% | 5,205 | 319.71K |
| 491 | LPCN | Lipocine Inc. | 15.18M | -2.35% | 720,996 | 1.98M |
| 492 | PHIO | Phio Pharmaceuticals Corp. | 14.58M | -3.46% | 49,940 | - |
| 493 | INTS | Intensity Therapeutics, Inc. | 14.20M | 1.60% | 7,964 | - |
| 494 | INAB | IN8bio, Inc. | 14.18M | -0.69% | 46,951 | - |
| 495 | JUNS | Jupiter Neurosciences, Inc. | 13.79M | 2.07% | 58,053 | 21.80K |
| 496 | MBRX | Moleculin Biotech, Inc. | 13.35M | 2.95% | 87,611 | - |
| 497 | BCDA | BioCardia, Inc. | 12.96M | -2.07% | 80,634 | 3.00K |
| 498 | CYCN | Cyclerion Therapeutics, Inc. | 12.81M | 4.84% | 2,020,342 | 2.07M |
| 499 | CVKD | Cadrenal Therapeutics, Inc. | 12.51M | 2.89% | 12,113 | - |
| 500 | KAPA | Kairos Pharma, Ltd. | 12.42M | -0.33% | 106,235 | - |